Profil
Bob Deresiewicz is currently a Director at Asher Biotherapeutics, Inc. Previously, he was a Senior Managing Director and Partner at Wellington Management Co. LLP (Private Equity) from 2000 to 2022.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York, a doctorate from Icahn School of Medicine at Mount Sinai, and an MBA from Harvard Business School.
Postes actifs de Bob Deresiewicz
| Sociétés | Poste | Début |
|---|---|---|
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Directeur/Membre du Conseil | 06/07/2022 |
Anciens postes connus de Bob Deresiewicz
| Sociétés | Poste | Fin |
|---|---|---|
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Private Equity Investor | 30/06/2022 |
Formation de Bob Deresiewicz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Finance |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
















